Ascendis Pharma A/S (ASND) NASDAQ
$112.93 (1.83) (-1.59%)
Market Cap: $6.48B
As of 09/11/24 04:00 PM EDT. Market closed.
Ascendis Pharma A/S (ASND)
NASDAQ
$112.93
(1.83) (-1.59%)
Market Cap: $6.48B
As of 09/11/24 04:00 PM EDT. Market closed.
Add to Portfolio
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jan Moller Mikkelsen
Full Time Employees
879
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jan Moller Mikkelsen
Full Time Employees
879
Address
Tuborg Boulevard 12, Hellerup, 2900.
PRICE CHART FOR ASCENDIS PHARMA A/S
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$116.03
Previous Close
$114.76
Days Range
$111.23 - $116.11
52 week range
$85.29 - $161
Volume
751,411
Avg. Volume (30 days)
417,620
Market Cap
$6.48B
Dividend Yield
-
P/E
(11.81)
Shares Outstanding
57,349,754
Open
$116.03
Previous Close
$114.76
Days Range
$111.23 - $116.11
52 week range
$85.29 - $161
Volume
751,411
Avg. Volume (30 days)
417,620
Market Cap
$6.48B
Dividend Yield
-
P/E
(11.81)
Shares Outstanding
57,349,754
FINANCIAL STATEMENTS FOR ASCENDIS PHARMA A/S
LOADING...
Open in: 
Open in:
FUNDS WITH A POSITION IN ASCENDIS PHARMA A/S
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10,108,400 | 18.23% | No change | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 820,512 | 0.21% | 291.63% | Other |
| BLACKROCK INC. | 405,989 | 0.00125% | 0.2% | Other |
| D. E. SHAW & CO., INC. | 281,537 | 0.04% | -17.22% | Other |
| CANDRIAM S.C.A. | 195,347 | 0.16% | 96.58% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 109,000 | 0.07% | Exited | Event Driven, Value |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 81,396 | 0.11% | -18.86% | Growth |
| SOROS FUND MANAGEMENT LLC | 100,000 | 0.25% | 2813.75% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 57,786 | 0.00069% | 3% | Other |
| TUDOR INVESTMENT CORP ET AL | 33,375 | 0.02% | New | Event Driven, Other |
| BALYASNY ASSET MANAGEMENT L.P. | 4,221 | 0.00101% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR ASCENDIS PHARMA A/S
STOCK BUYBACKS FOR ASCENDIS PHARMA A/S
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2024
0.81%
1Q
12/31/2023
1.38%
2Q
09/30/2023
1.91%
3Q
06/30/2023
2.01%
4Q
03/31/2023
2.24%
5Q
12/31/2022
2.51%
6Q
09/30/2022
2.71%
7Q
06/30/2022
2.76%
8Q
03/31/2022
1.10%
9Q
12/31/2021
0.91%
10Q
09/30/2021
4.95%
11Q
06/30/2021
6.50%
12Q
03/31/2021
6.67%
13Q
12/31/2020
7.14%
14Q
09/30/2020
8.78%
15Q
06/30/2020
18.96%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ASCENDIS PHARMA A/S
LOADING...